Clinical Impact of Epileptiform Discharge in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Eun Hye Lee1, Yong Sung Choi2, Hoi Soo Yoon2

  • 1Department of Pediatrics, College of Medicine, Kyung Hee University, Seoul, Korea leeeh80@khmc.or.kr.

Journal of Child Neurology
|September 6, 2015
PubMed

Insights

Epileptiform discharges, abnormal electrical activity in the brain, are common in children with attention-deficit/hyperactivity disorder (ADHD). These discharges may indicate an increased risk for developing epilepsy in ADHD patients.

Area of Science:

  • Neuroscience
  • Pediatrics
  • Clinical Neurology

Background:

  • Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder.
  • The relationship between ADHD and epilepsy, particularly the presence of epileptiform discharges, requires further investigation.

Purpose of the Study:

  • To determine the prevalence of epileptiform discharges in children diagnosed with ADHD.
  • To explore the clinical significance and potential association with epilepsy in this population.

Main Methods:

  • Retrospective review of 180 children diagnosed with ADHD.
  • Analysis of electroencephalography (EEG) recordings to identify epileptiform discharges.
  • Correlation of EEG findings with clinical history, including epilepsy and seizure occurrence.

Main Results:

  • Epileptiform discharges were identified in 16.1% of ADHD patients.
  • Both generalized (8.3%) and focal (7.7%) epileptiform discharges were observed.
  • Focal discharges were most common in frontal and rolandic areas.
  • Patients with epileptiform discharges had a higher incidence of prior or subsequent epilepsy diagnosis compared to those without.

Conclusions:

  • Interictal epileptiform discharges are associated with seizure occurrence in children with ADHD.
  • These findings suggest overlapping maturational pathophysiology between ADHD and epilepsy.
  • EEG evaluation may be beneficial for identifying ADHD patients at risk for epilepsy.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.3K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.2K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K